Gossamer Bio, Inc.
GOSS
$2.00
-$0.04-1.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -9.50% | 3.73% | -8.48% | -13.10% | -5.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.30% | 16.60% | 7.18% | -5.47% | -12.45% |
| Operating Income | 12.27% | 7.43% | 16.23% | 212.54% | 12.45% |
| Income Before Tax | 12.62% | 26.40% | 20.18% | 226.29% | 14.72% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 12.62% | 31.40% | 23.01% | 215.85% | 14.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.62% | 31.40% | 23.01% | 215.85% | 14.72% |
| EBIT | 12.27% | 7.43% | 16.23% | 212.54% | 12.45% |
| EBITDA | 11.74% | 7.01% | 15.96% | 214.22% | 12.14% |
| EPS Basic | 13.03% | -36.47% | 34.38% | 148.88% | 64.16% |
| Normalized Basic EPS | 13.01% | -102.65% | 31.94% | 153.31% | 65.23% |
| EPS Diluted | 13.03% | -36.47% | 34.38% | 148.20% | 64.29% |
| Normalized Diluted EPS | 13.01% | -102.65% | 31.94% | 150.54% | 65.23% |
| Average Basic Shares Outstanding | 0.48% | 0.53% | 17.35% | 137.01% | 137.94% |
| Average Diluted Shares Outstanding | 0.48% | 0.53% | 17.35% | 149.92% | 137.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |